236 related articles for article (PubMed ID: 10403418)
1. Role of dimorphism in the development of Candida albicans biofilms.
Baillie GS; Douglas LJ
J Med Microbiol; 1999 Jul; 48(7):671-679. PubMed ID: 10403418
[TBL] [Abstract][Full Text] [Related]
2. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.
Al-Fattani MA; Douglas LJ
J Med Microbiol; 2006 Aug; 55(Pt 8):999-1008. PubMed ID: 16849719
[TBL] [Abstract][Full Text] [Related]
3. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans.
Ramage G; VandeWalle K; López-Ribot JL; Wickes BL
FEMS Microbiol Lett; 2002 Aug; 214(1):95-100. PubMed ID: 12204378
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.
Haque F; Alfatah M; Ganesan K; Bhattacharyya MS
Sci Rep; 2016 Mar; 6():23575. PubMed ID: 27030404
[TBL] [Abstract][Full Text] [Related]
5. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity against Candida biofilms.
Iñigo M; Pemán J; Del Pozo JL
Int J Artif Organs; 2012 Oct; 35(10):780-91. PubMed ID: 23138707
[TBL] [Abstract][Full Text] [Related]
7. In vitro method to study antifungal perfusion in Candida biofilms.
Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
[TBL] [Abstract][Full Text] [Related]
8. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model.
Andes D; Nett J; Oschel P; Albrecht R; Marchillo K; Pitula A
Infect Immun; 2004 Oct; 72(10):6023-31. PubMed ID: 15385506
[TBL] [Abstract][Full Text] [Related]
10. Biofilm development by blastospores and hyphae of Candida albicans on abraded denture acrylic resin surfaces.
Jackson S; Coulthwaite L; Loewy Z; Scallan A; Verran J
J Prosthet Dent; 2014 Oct; 112(4):988-93. PubMed ID: 24726593
[TBL] [Abstract][Full Text] [Related]
11. [Candida biofilm formation on Provox 2 and Provox Acti Valve voice prosthesis].
Nowak M; Kurnatowski P
Otolaryngol Pol; 2010; 64(6):358-64. PubMed ID: 21302502
[TBL] [Abstract][Full Text] [Related]
12. Penetration of Candida biofilms by antifungal agents.
Al-Fattani MA; Douglas LJ
Antimicrob Agents Chemother; 2004 Sep; 48(9):3291-7. PubMed ID: 15328087
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms.
Mukherjee PK; Long L; Kim HG; Ghannoum MA
Int J Antimicrob Agents; 2009 Feb; 33(2):149-53. PubMed ID: 18945596
[TBL] [Abstract][Full Text] [Related]
14. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
[TBL] [Abstract][Full Text] [Related]
15. Effects of extracellular DNA from Candida albicans and pneumonia-related pathogens on Candida biofilm formation and hyphal transformation.
Sapaar B; Nur A; Hirota K; Yumoto H; Murakami K; Amoh T; Matsuo T; Ichikawa T; Miyake Y
J Appl Microbiol; 2014 Jun; 116(6):1531-42. PubMed ID: 24661775
[TBL] [Abstract][Full Text] [Related]
16. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
Khan MS; Ahmad I
J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-throughput Candida albicans biofilm chip.
Srinivasan A; Uppuluri P; Lopez-Ribot J; Ramasubramanian AK
PLoS One; 2011 Apr; 6(4):e19036. PubMed ID: 21544190
[TBL] [Abstract][Full Text] [Related]
18. Non-glucan attached proteins of Candida albicans biofilm formed on various surfaces.
Vediyappan G; Chaffin WL
Mycopathologia; 2006 Jan; 161(1):3-10. PubMed ID: 16389478
[TBL] [Abstract][Full Text] [Related]
19. Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms.
Luiz RL; Vila TV; de Mello JC; Nakamura CV; Rozental S; Ishida K
BMC Complement Altern Med; 2015 Mar; 15():68. PubMed ID: 25886244
[TBL] [Abstract][Full Text] [Related]
20. Lab-scale preparations of Candida albicans and dual Candida albicans-Candida glabrata biofilms on the surface of medical-grade polyvinyl chloride (PVC) perfusion tube using a modified gravity-supported free-flow biofilm incubator (GS-FFBI).
Shao J; Lu K; Tian G; Cui Y; Yan Y; Wang T; Zhang X; Wang C
J Microbiol Methods; 2015 Feb; 109():41-8. PubMed ID: 25528294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
